This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Stewart KA, Natzke BM, Williams T, Granger E, Casscells SW, Croghan TW.Temporal trends in anti-diabetes drug use in tricare following safety warnings in 2007 about rosiglitazone. Pharmacoepidemiology and Drug Safety 18: 1048-1052, No. 11, Nov 2009
Rights and permissions
About this article
Cite this article
Antihyperglycaemics: prescribing rate unchanged by rosiglitazone warning. Pharmacoecon. Outcomes News 593, 4 (2009). https://doi.org/10.2165/00151234-200905930-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905930-00011